Earnings Call · Q2 FY2023·2023-08-06

Q2 23EPS +46.15%·Rev n/aQ1 23EPS +27.27%·Rev n/aQ4 22EPS -3.33%·Rev n/aQ3 22EPS +4.55%·Rev n/a⚠ consensus missing

Alignment Healthcare, Inc. ALHC

John Kao — Chief Executive Officer

Thomas Freeman — Chief Financial Officer

+11.6%1d on move date+12.0% vs SPY3d+14.7%5d+13.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALHC calls or request research access.

More ALHC calls Browse calls Request research access